Author:
Publisher:
ISBN:
Category : Agricultural biotechnology
Languages : en
Pages : 1120
Book Description
Biotech Reporter
Author:
Publisher:
ISBN:
Category : Agricultural biotechnology
Languages : en
Pages : 1120
Book Description
Publisher:
ISBN:
Category : Agricultural biotechnology
Languages : en
Pages : 1120
Book Description
The Biotech Investor
Author: Tom Abate
Publisher: Times Books
ISBN: 146685121X
Category : Business & Economics
Languages : en
Pages : 308
Book Description
A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Publisher: Times Books
ISBN: 146685121X
Category : Business & Economics
Languages : en
Pages : 308
Book Description
A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Biopunk
Author: Marcus Wohlsen
Publisher: Penguin
ISBN: 1617230073
Category : Science
Languages : en
Pages : 274
Book Description
Bill Gates recently told Wired that if he were a teenager today, he would be hacking biology. "If you want to change the world in some big way," he says, "that's where you should start-biological molecules." The most disruptive force on the planet resides in DNA. Biotech companies and academic researchers are just beginning to unlock the potential of piecing together life from scratch. Champions of synthetic biology believe that turning genetic code into Lego-like blocks to build never-before-seen organisms could solve the thorniest challenges in medicine, energy, and environmental protection. But as the hackers who cracked open the potential of the personal computer and the Internet proved, the most revolutionary discoveries often emerge from out-of-the-way places, forged by brilliant outsiders with few resources besides boundless energy and great ideas. In Biopunk, Marcus Wohlsen chronicles a growing community of DIY scientists working outside the walls of corporations and universities who are committed to democratizing DNA the way the Internet did information. The "biohacking" movement, now in its early, heady days, aims to unleash an outbreak of genetically modified innovation by making the tools and techniques of biotechnology accessible to everyone. Borrowing their idealism from the worlds of open-source software, artisinal food, Internet startups, and the Peace Corps, biopunks are devoted advocates for open-sourcing the basic code of life. They believe in the power of individuals with access to DNA to solve the world's biggest problems. You'll meet a new breed of hackers who aren't afraid to get their hands wet, from entrepreneurs who aim to bring DNA-based medical tools to the poorest of the poor to a curious tinkerer who believes a tub of yogurt and a jellyfish gene could protect the world's food supply. These biohackers include: -A duo who started a cancer drug company in their kitchen -A team who built an open-source DNA copy machine -A woman who developed a genetic test in her apartment for a deadly disease that had stricken her family Along with the potential of citizen science to bring about disruptive change, Wohlsen explores the risks of DIY bioterrorism, the possibility of genetic engineering experiments gone awry, and whether the ability to design life from scratch on a laptop might come sooner than we think.
Publisher: Penguin
ISBN: 1617230073
Category : Science
Languages : en
Pages : 274
Book Description
Bill Gates recently told Wired that if he were a teenager today, he would be hacking biology. "If you want to change the world in some big way," he says, "that's where you should start-biological molecules." The most disruptive force on the planet resides in DNA. Biotech companies and academic researchers are just beginning to unlock the potential of piecing together life from scratch. Champions of synthetic biology believe that turning genetic code into Lego-like blocks to build never-before-seen organisms could solve the thorniest challenges in medicine, energy, and environmental protection. But as the hackers who cracked open the potential of the personal computer and the Internet proved, the most revolutionary discoveries often emerge from out-of-the-way places, forged by brilliant outsiders with few resources besides boundless energy and great ideas. In Biopunk, Marcus Wohlsen chronicles a growing community of DIY scientists working outside the walls of corporations and universities who are committed to democratizing DNA the way the Internet did information. The "biohacking" movement, now in its early, heady days, aims to unleash an outbreak of genetically modified innovation by making the tools and techniques of biotechnology accessible to everyone. Borrowing their idealism from the worlds of open-source software, artisinal food, Internet startups, and the Peace Corps, biopunks are devoted advocates for open-sourcing the basic code of life. They believe in the power of individuals with access to DNA to solve the world's biggest problems. You'll meet a new breed of hackers who aren't afraid to get their hands wet, from entrepreneurs who aim to bring DNA-based medical tools to the poorest of the poor to a curious tinkerer who believes a tub of yogurt and a jellyfish gene could protect the world's food supply. These biohackers include: -A duo who started a cancer drug company in their kitchen -A team who built an open-source DNA copy machine -A woman who developed a genetic test in her apartment for a deadly disease that had stricken her family Along with the potential of citizen science to bring about disruptive change, Wohlsen explores the risks of DIY bioterrorism, the possibility of genetic engineering experiments gone awry, and whether the ability to design life from scratch on a laptop might come sooner than we think.
BioEvolution
Author: Michael Fumento
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 530
Book Description
"Fumento takes the reader behind the scenes of the biotechnology business while lucidly explaining the scientific underpinnings of medical research." -- William W. Li, M.D., President, The Angiogenesis Foundation.
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 530
Book Description
"Fumento takes the reader behind the scenes of the biotechnology business while lucidly explaining the scientific underpinnings of medical research." -- William W. Li, M.D., President, The Angiogenesis Foundation.
Preparing for Future Products of Biotechnology
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309452058
Category : Science
Languages : en
Pages : 231
Book Description
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
Publisher: National Academies Press
ISBN: 0309452058
Category : Science
Languages : en
Pages : 231
Book Description
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
AgBiotech Reporter
Author:
Publisher:
ISBN:
Category : Agricultural biotechnology
Languages : en
Pages : 794
Book Description
Publisher:
ISBN:
Category : Agricultural biotechnology
Languages : en
Pages : 794
Book Description
Bad Blood
Author: John Carreyrou
Publisher: Vintage
ISBN: 1524731668
Category : Business & Economics
Languages : en
Pages : 354
Book Description
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close. “Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Publisher: Vintage
ISBN: 1524731668
Category : Business & Economics
Languages : en
Pages : 354
Book Description
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close. “Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition
Author:
Publisher: ScholarlyEditions
ISBN: 1490108734
Category : Science
Languages : en
Pages : 1177
Book Description
Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Biotechnology. The editors have built Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Biotechnology in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Publisher: ScholarlyEditions
ISBN: 1490108734
Category : Science
Languages : en
Pages : 1177
Book Description
Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Biotechnology. The editors have built Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Biotechnology in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Biotechnology and Medical Technology Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition
Author:
Publisher: ScholarlyEditions
ISBN: 1490108505
Category : Science
Languages : en
Pages : 288
Book Description
Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Marine Biotechnology. The editors have built Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Marine Biotechnology in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Publisher: ScholarlyEditions
ISBN: 1490108505
Category : Science
Languages : en
Pages : 288
Book Description
Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Marine Biotechnology. The editors have built Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Marine Biotechnology in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Animal, Marine, Food, and Industrial Biotechnology: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Making Health Public
Author: Charles L. Briggs
Publisher: Routledge
ISBN: 1317329872
Category : Social Science
Languages : en
Pages : 259
Book Description
This book examines the relationship between media and medicine, considering the fundamental role of news coverage in constructing wider cultural understandings of health and disease. The authors advance the notion of ‘biomediatization’ and demonstrate how health knowledge is co-produced through connections between dispersed sites and forms of expertise. The chapters offer an innovative combination of media content analysis and ethnographic data on the production and circulation of health news, drawing on work with journalists, clinicians, health officials, medical researchers, marketers, and audiences. The volume provides students and scholars with unique insight into the significance and complexity of what health news does and how it is created.
Publisher: Routledge
ISBN: 1317329872
Category : Social Science
Languages : en
Pages : 259
Book Description
This book examines the relationship between media and medicine, considering the fundamental role of news coverage in constructing wider cultural understandings of health and disease. The authors advance the notion of ‘biomediatization’ and demonstrate how health knowledge is co-produced through connections between dispersed sites and forms of expertise. The chapters offer an innovative combination of media content analysis and ethnographic data on the production and circulation of health news, drawing on work with journalists, clinicians, health officials, medical researchers, marketers, and audiences. The volume provides students and scholars with unique insight into the significance and complexity of what health news does and how it is created.